BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2009
View Archived Issues
Clinical studies reveal efficacy of bepotastine in treating allergic conjunctivitis
Read More
Fourth quarter highlights at Merck KGaA
Read More
Novel substituted tetrahydronaphthalines claimed by sanofi-aventis
Read More
Novel b-Raf inhibitors claimed by Takeda
Read More
Agile signs clinical trial agreement for its progestin-only contraceptive patch AG-1000
Read More
FDA issues complete response letter to Dyax regarding BLA for DX-88 in HAE
Read More
Biogen Idec reports favorable interim results from phase IIa studies of BIIB-014 in PD
Read More
Infinity initiates phase II IPI-504 trial in HER2-positive breast cancer
Read More
Faron presents update on its lead compoumd Traumakine
Read More
FDA clears Curemark's IND for phase III clinical trial of CM-AT in autism
Read More
reMYND presents first-in-class drug candidates for Alzheimer's, Parkinson's disease
Read More
Oral MC-4 receptor antagonists developed by Santhera for cachexia
Read More
Novel compounds for the treatment of mood disorders presented by GlaxoSmithKline
Read More
Boehringer Ingelheim claims the discovery of novel arylsulfonamides with analgesic activity
Read More
Novel phosphodiesterase type 10 inhibitors claimed by Amgen
Read More
Portola Pharmaceuticals describes second-generation P2Y12 inhibitors
Read More
Dual specificity antibody displays in vitro and in vivo antiproliferative activity
Read More
Tadalafil improves benign prostatic hyperplasia symptoms regardless of erectile function status
Read More
Archemix initiates phase IIa ARC-1779 trial
Read More
EffRx signs expansion of licensing deal with Nycomed for EX-101
Read More
AstraZeneca to meet with FDA Psychopharmacologic Drugs Advisory Committee
Read More
Seattle Genetics receives FDA fast track for SGN-35 for Hodgkin's lymphoma
Read More
Arena reports pivotal phase III results for lorcaserin in obesity
Read More
PharmaMar and Taiho sign license agreement for antitumor drug Yondelis in Japan
Read More
Ixiaro vaccine receives FDA approval for Japanese encephalitis prevention
Read More
FDA approves Afinitor in patients with advanced kidney cancer
Read More